A Case of Isolated CNS Relapse in a CML Patient on Chronic Phase

Morillo, Laurence Adlai B. and Zapata-Mesina, Flordeluna and Castillo, Ma Rosario Irene D. (2015) A Case of Isolated CNS Relapse in a CML Patient on Chronic Phase. International Blood Research & Reviews, 4 (2). pp. 1-8. ISSN 23217219

[thumbnail of Mesina422015IBRR17731.pdf] Text
Mesina422015IBRR17731.pdf - Published Version

Download (339kB)

Abstract

We report a patient who achieved hematologic response with Imatinib mesylate and is in chronic phase, but after several years developed neurologic symptoms and was eventually documented to have an isolated CNS relapse. The patient was treated with intrathecal chemotherapy to clear the spinal fluid of the leukemia cells. Imatinib mesylate (STI-571) is a potent and selective inhibitor of BCR-ABL tyrosine kinase and has emerged as a treatment of choice in chronic myeloid leukaemia. However because of poor penetration of the drug to the blood-brain barrier of the central nervous system (CNS), then the CNS acts as a sanctuary site for malignant cells.

Item Type: Article
Subjects: Pustaka Library > Medical Science
Depositing User: Unnamed user with email support@pustakalibrary.com
Date Deposited: 13 Jul 2023 04:38
Last Modified: 23 Jan 2024 04:44
URI: http://archive.bionaturalists.in/id/eprint/1029

Actions (login required)

View Item
View Item